Detailed information for compound 105398

Basic information

Technical information
  • TDR Targets ID: 105398
  • Name: 1-[(4R)-4-(pyrrolidine-1-carbonyl)-1,3-thiazo lidin-3-yl]-2-(6,7,8,9-tetrahydro-5H-benzo[7] annulen-8-yl)ethanone
  • MW: 372.524 | Formula: C21H28N2O2S
  • H donors: 0 H acceptors: 2 LogP: 3.56 Rotable bonds: 5
    Rule of 5 violations (Lipinski): 1
  • SMILES: O=C(N1CSC[C@H]1C(=O)N1CCCC1)CC1CCCc2c(C1)cccc2
  • InChi: 1S/C21H28N2O2S/c24-20(13-16-6-5-9-17-7-1-2-8-18(17)12-16)23-15-26-14-19(23)21(25)22-10-3-4-11-22/h1-2,7-8,16,19H,3-6,9-15H2/t16?,19-/m0/s1
  • InChiKey: ROGAPHOWRGLVQR-CVMIBEPCSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • 1-[(4R)-4-(pyrrolidine-1-carbonyl)thiazolidin-3-yl]-2-(6,7,8,9-tetrahydro-5H-benzo[7]annulen-8-yl)ethanone
  • 1-[(4R)-4-[oxo(1-pyrrolidinyl)methyl]-3-thiazolidinyl]-2-(6,7,8,9-tetrahydro-5H-benzo[7]annulen-8-yl)ethanone
  • 1-[(4R)-4-pyrrolidin-1-ylcarbonyl-1,3-thiazolidin-3-yl]-2-(6,7,8,9-tetrahydro-5H-benzo[7]annulen-8-yl)ethanone
  • 1-[(4R)-4-(pyrrolidine-1-carbonyl)thiazolidin-3-yl]-2-(6,7,8,9-tetrahydro-5H-benzocyclohepten-8-yl)ethanone
  • 1-[(4R)-4-(oxo-1-pyrrolidinylmethyl)-3-thiazolidinyl]-2-(6,7,8,9-tetrahydro-5H-benzo[7]annulen-8-yl)ethanone

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens prolyl endopeptidase Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Onchocerca volvulus Prolyl endopeptidase homolog Get druggable targets OG5_129295 All targets in OG5_129295
Trypanosoma cruzi prolyl endopeptidase Get druggable targets OG5_129295 All targets in OG5_129295
Leishmania mexicana prolyl oligopeptidase, putative Get druggable targets OG5_129295 All targets in OG5_129295
Leishmania infantum prolyl oligopeptidase, putative,serine peptidase clan SC, family S9A, putative Get druggable targets OG5_129295 All targets in OG5_129295
Trypanosoma brucei gambiense prolyl oligopeptidase, putative,serine peptidase clan SC, family S9A, putative Get druggable targets OG5_129295 All targets in OG5_129295
Schistosoma japonicum ko:K01322 prolyl oligopeptidase [EC3.4.21.26], putative Get druggable targets OG5_129295 All targets in OG5_129295
Neospora caninum Prolyl oligopeptidase (EC 3.4.21.26) (Precursor), related Get druggable targets OG5_129295 All targets in OG5_129295
Leishmania major prolyl oligopeptidase, putative,serine peptidase clan SC, family S9A, putative Get druggable targets OG5_129295 All targets in OG5_129295
Leishmania donovani prolyl endopeptidase Get druggable targets OG5_129295 All targets in OG5_129295
Schistosoma mansoni prolyl oligopeptidase (S09 family) Get druggable targets OG5_129295 All targets in OG5_129295
Echinococcus granulosus prolyl endopeptidase Get druggable targets OG5_129295 All targets in OG5_129295
Toxoplasma gondii prolyl endopeptidase Get druggable targets OG5_129295 All targets in OG5_129295
Schistosoma japonicum Prolyl endopeptidase, putative Get druggable targets OG5_129295 All targets in OG5_129295
Schistosoma mansoni prolyl oligopeptidase (S09 family) Get druggable targets OG5_129295 All targets in OG5_129295
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_129295 All targets in OG5_129295
Echinococcus multilocularis prolyl endopeptidase Get druggable targets OG5_129295 All targets in OG5_129295
Mycobacterium tuberculosis Probable protease II PtrBa [first part] (oligopeptidase B) Get druggable targets OG5_129295 All targets in OG5_129295
Trypanosoma congolense prolyl endopeptidase Get druggable targets OG5_129295 All targets in OG5_129295
Trypanosoma brucei prolyl endopeptidase Get druggable targets OG5_129295 All targets in OG5_129295
Brugia malayi prolyl oligopeptidase family protein Get druggable targets OG5_129295 All targets in OG5_129295

By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Trypanosoma brucei oligopeptidase b prolyl endopeptidase 710 aa 630 aa 27.0 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Trypanosoma brucei prolyl endopeptidase 0.0158 1 1
Trypanosoma cruzi prolyl endopeptidase 0.0158 1 1
Schistosoma mansoni prolyl oligopeptidase (S09 family) 0.0158 1 1
Mycobacterium ulcerans protease II (oligopeptidase B), PtrB 0.0063 0.3271 0.5
Toxoplasma gondii prolyl endopeptidase 0.0158 1 0.5
Schistosoma mansoni tar DNA-binding protein 0.0063 0.3255 0.3255
Loa Loa (eye worm) hypothetical protein 0.0158 1 1
Mycobacterium tuberculosis Probable protease II PtrBa [first part] (oligopeptidase B) 0.0142 0.8828 1
Schistosoma mansoni tar DNA-binding protein 0.0063 0.3255 0.3255
Trypanosoma cruzi oligopeptidase B-like protein, putative 0.0063 0.3271 0.3271
Echinococcus granulosus prolyl endopeptidase 0.0158 1 1
Schistosoma mansoni tar DNA-binding protein 0.0063 0.3255 0.3255
Mycobacterium leprae PROBABLE PROTEASE II PTRBB (OLIGOPEPTIDASE B) 0.0063 0.3271 0.5
Schistosoma mansoni prolyl oligopeptidase (S09 family) 0.0158 1 1
Leishmania major prolyl oligopeptidase, putative,serine peptidase clan SC, family S9A, putative 0.0158 1 1
Onchocerca volvulus Prolyl endopeptidase homolog 0.0158 1 0.5
Schistosoma mansoni tar DNA-binding protein 0.0063 0.3255 0.3255
Trypanosoma cruzi serine peptidase, clan SC, family S9A-like protein, putative 0.0063 0.3271 0.3271
Trypanosoma cruzi oligopeptidase b 0.0063 0.3271 0.3271
Trypanosoma cruzi oligopeptidase b 0.0063 0.3271 0.3271
Schistosoma mansoni tar DNA-binding protein 0.0063 0.3255 0.3255
Echinococcus multilocularis prolyl endopeptidase 0.0158 1 1

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 150 nM In vitro inhibitory activity against purified prolyl endopeptidase (PEP) from canine brain. ChEMBL. 8027988
IC50 (binding) = 150 nM In vitro inhibitory activity against purified prolyl endopeptidase (PEP) from canine brain. ChEMBL. 8027988
IC50 (binding) = 250 nM In vitro inhibitory activity against purified prolyl endopeptidase (PEP) from canine brain. ChEMBL. 8027988
IC50 (binding) = 250 nM In vitro inhibitory activity against purified prolyl endopeptidase (PEP) from canine brain. ChEMBL. 8027988

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.